Vibose 0.3mg Tablet

Uses of Vibose 0.3mg Tablet

• Treats type 2 diabetes mellitus along with diet and exercise

How does Vibose 0.3mg Tablet work?

Vibose 0.3mg Tablet works by stopping the intestinal enzymes responsible for breaking down complex sugars into simple sugars such as glucose. This helps in reducing the sugar levels in the blood after food.

Side Effects of Vibose 0.3mg Tablet

Common Side Effects:

• Soft stools or diarrhea
• Flatulence (gas)
• Abdominal pain or discomfort
• Nausea

Rare side Effects:

• Headache
• Anemia
• Signs of low platelet levels (easy bleeding or bruising)
• Signs of low white blood cells (repeated infections)
• Numbness
• Edema (swelling) of the face
• Blurred vision
• Hot flushes
• General discomfort
• Weakness
• Signs of high potassium levels in blood (irregular heartbeat, muscle weakness, chest pain)
• Excessive sweating
• Hair loss

Quick Suggestions:

• Include foods rich in healthy carbohydrates, fiber, fruits, whole grains, and vegetables in your meals. Eat at regular intervals and avoid skipping meals or overeating.
• Walk for at least 45 minutes daily to complement the effects of Vibose 0.3mg Tablet. Maintaining a healthy weight through exercise is important for managing diabetes.
• Practice meditation, yoga, or other relaxation techniques to manage stress, as stress can impact blood sugar levels.
• Vibose 0.3mg Tablet is meant to work alongside other diabetes medicines. It's important to continue your exercise regimen, follow a healthy diet, and take your other prescribed medicines.
• Take Voglibose before meals to lower post-meal blood sugar levels effectively.
• Some initial side effects like stomach pain, gas, and diarrhea may occur during the first weeks of treatment. They usually improve over time.
• Regularly monitor your blood glucose levels to ensure they are within the target range.
• Take Vibose 0.3mg Tablet as prescribed by your doctor. Avoid skipping doses and continue the treatment plan for the recommended duration.
• Your doctor may recommend regular tests to monitor your liver function while using Vibose 0.3mg Tablet.

Indication of Vibose 0.3mg Tablet

Type 2 diabetes mellitus, commonly referred to as non-insulin-dependent diabetes, is a chronic condition that disrupts the body's proper utilization of insulin. Insulin, a hormone, plays a crucial role in regulating blood glucose levels. In type 2 diabetes, either insufficient insulin is produced or the insulin produced faces resistance within the body, leading to elevated blood sugar levels.

Typically observed in middle-aged or older individuals, type 2 diabetes is often termed adult-onset diabetes. Its symptoms encompass various indications such as fatigue, frequent urination, excessive thirst, dry mouth, blurred vision, constant hunger, weight loss, and itchy skin.

Vibose 0.3mg Tablet functions as an antidiabetic medication that targets post-meal blood glucose levels in patients with type 2 diabetes. Alongside dietary and lifestyle modifications, this medicine aids in enhancing blood sugar levels.

Pharmacology

Vibose 0.3mg Tablet shares comparable characteristics with acarbose and operates by specifically inhibiting α-glucosidase within the digestive tract. This action results in the slowdown of carbohydrate digestion and absorption, effectively curbing the rapid surge in post-meal plasma glucose levels.

Dosage & Administration of Vibose 0.3mg Tablet

• For adults with Diabetes mellitus, the typical dosage is 200-300 mcg three times a day.
• Elderly patients should begin at lower doses. AdministerVibose 0.3mg Tablet with food, right before meals.
• Always follow your physician's guidance regarding the proper dose and duration of Vibose 0.3mg Tablet, based on your age, body weight, and medical condition.

Interaction

Individuals can experience varied interactions with different medications. Prior to initiating any medicine, it's crucial to discuss potential interactions with your healthcare provider.

Interaction with Alcohol: Refrain from consuming alcohol while taking Vibose 0.3mg Tablet, as it could result in low blood pressure.

Interaction with Medicine: 

• Other antidiabetic drugs (e.g., glipizide, tolbutamide, insulin) used for diabetes management
• Medications for heart conditions (e.g., metoprolol, atenolol)
• Drugs for skin infections (e.g., salicylic acid)
• Antidepressants (e.g., phenelzine, selegiline)
• Cholesterol-lowering drugs (e.g., fenofibrate)
• Epinephrine (used to manage severe allergic reactions)
• Adrenocorticotrophin (for pituitary or adrenal gland disorders like Cushing's syndrome)
• Thyroxine (for thyroid issues)

In case of an overdose, immediately consult your doctor or seek medical attention. Overdosing might lead to symptoms like low blood sugar levels, abdominal discomfort, and diarrhea. This is not an exhaustive list; consult your doctor regarding all possible drug interactions and their effects.

Contraindications

Vibose 0.3mg Tablet should not be used in the following situations or conditions:

• Inflammatory bowel disease
• Gastrointestinal obstruction or patients prone to it
• Conditions that may worsen due to increased gas formation, such as hernia
• Severe ketosis
• Diabetic coma or pre-coma
• Severe infection
• Hypersensitivity to the medication
• During pregnancy
• While breastfeeding

Additionally, Vibose 0.3mg Tablet should not be used as monotherapy in individuals with insulin-dependent diabetes mellitus (IDDM). It's important to adhere to these contraindications and consult your doctor for appropriate guidance.

Pregnancy & Lactation

Pregnancy: The safety of Voglibose during pregnancy has yet to be determined. However, no adequate and well-controlled studies on pregnant women have been conducted.

Lactating and nursing mothers: Despite the fact that the levels of Voglibose found in human milk are extremely low, it is not recommended that Voglibose be given to these women.

Precautions & Warnings

Vibose 0.3mg Tablet should be administered with caution to the following groups of patients:

• Patients who are already taking other anti-diabetic medications, as there is a risk of hypoglycemia (low blood sugar).
• Patients with a history of laparotomy (surgical incision into the abdominal cavity) or ileus (intestinal obstruction).
• Patients with a history of Roemheld's syndrome (a condition involving gastrointestinal and cardiac symptoms) or stenosis (narrowing of a passage in the body).
• Patients with severe hepatic (liver) or renal (kidney) impairment.
• Children under the age of 18 and elderly patients.
• It's important to monitor liver function (LFT) during treatment.
• Hypoglycemic episodes (low blood sugar) should be managed with glucose, not sucrose.

Additionally, caution is advised in patients who have had a laparotomy or ileus, as they might experience symptoms related to increased intestinal gas or other digestive issues.

Storage Conditions

Keep the temperature below and away from light and moisture. Keep out of children's reach.